Evolution of secondary hyperparathyroidism after renal transplantation

Pediatric Nephrology

Volumn 14, Issue 4, 2000, Pages 342-346

  Koch Nogueira, Paulo C ^a   David, Louis ^a   Cochat, Pierre ^a,b  

^a UNIVERSITÉ LYON 1   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Kidney transplant; Renal osteodystrophy; Secondary hyperparathyroidism

Indexed keywords

CALCITRIOL; CYTOKINE; GROWTH FACTOR; IMMUNOSUPPRESSIVE AGENT; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHATE;

ADULT; BONE REMODELING; CONTROLLED STUDY; DIALYSIS; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; HUMAN; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; REVIEW; SECONDARY HYPERPARATHYROIDISM;

EID: 0034106014     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670050772     Document Type: Review

References (32)

1. Hory B, Drucke TB (1997) The parathyroid-bone axis in uremia: new insights into old questions. Curr Opin Nephrol Hypertens 6:40-48
2. Massari PA (1997) Disorders of bone and mineral metabolism after renal transplantation. Kidney Int 52:1412-1421
3. Feber J, Cochat P, Braillon P, Castelo F, Martin X, Glastre C, Chapuis F, David L, Meunier PJ (1994) Bone mineral density after renal transplantation. J Pediatr 125:870-875
4. Apel DM, Millar EA, Moel DI (1989) Skeletal disorders in a pediatric renal transplant population. J Pediatr Orthop 9:505-511
5. Sanchez CP, Salusky IB, Kuizon BD, Ramirez JA, Gales B, Ettenger RB, Goodman WG (1998) Bone disease in children and adolescents undergoing successful renal transplantation Kidney Int 53:1358-1364
6. Geis WP, Popovtzer MM, Corman JL, Halgrimson CG, Groth CG, Starzl TE (1973) The diagnosis and treatment of hyperparathyroidism after renal homotransplantation. Surg Gynecol Obstet 137:997-1010
7. Kleerekoper M, Ibels LS, Ingham JP, McCarthy SW, Mahony JF, Steward JH, Posen S (1975) Hyperparathyroidism after renal transplantation. BMJ 3:680-682
8. Bernheim J, Tourraine JL, David L, Faivre JM, Traeger J (1976) Evolution of secondary hyperparathyroidism after renal transplantation. Nephron 16:381-387
9. Pletka PG, Strom TB, Hampers CL, Griffiths H, Wilson RE, Bernstein DS, Sherwood LM, Merrill JP (1976) Secondary hyperparathyroidism in human kidney transplant recipients. Nephron 17:371-381
10. Pietschmann P, Vychytil A, Woloszczuk W, Kovarik J (1991) Bone metabolism with functioning kidney grafts: increased serum levels of osteocalcin and parathyroid hormone despite normalisation of kidney function. Nephron 59:533-536
11. Dumoulin G, Hory B, Nguyen NU, Bresson C, Fournier V, Bouhaddi M, Chalopin JM, Saint-Hillier Y, Regnard J (1997) No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant patients. Am J Kidney Dis 29:746-753
12. Mulrow CD, Oxman AD (eds) Cochrane Collaboration Handbook (updated 9 December 1996). Available in The Cochrane Library (database on disk and CDROM). The Cochrane Collaboration; issue 1. Update Software, Oxford, 1997. Updated quarterly
13. Gonzales MT, Gonzales C, Griñó JM, Castelao AM, Mariñoso ML, Serrano S, Bonnin R, Carreras L, Alsina J (1990) Long-term evolution of renal osteodystrophy after kidney transplantation: comparative study between intact PTH levels and bone biopsy. Transplant Proc 22:1407-1411
14. Torres A, Rodríguez AP, Concepcíon MT, García S, Rufino M, Martín B, Pérez L, Machado M, Bonis E, Losada M, Hernandéz D, Lorenzo V (1998) Parathyroid function in long-term renal transplant patients: importance of pre-transplant PTH concentrations. Nephrol Dial Transplant 13 [Suppl 3]:94-97
15. Uda S, Yoshimura A, Sugenoya Y, Inui K, Iwasaki S, Taira T, Ideura T (1996) Role of apoptosis in the progression of secondary hyperparathyroidism. Nippon Jinzo Gakkai Shi 38: 323-328
16. Fukuda N, Tanaka H, Tominaga Y, Fukugawa M, Kurokawa K, Seino Y (1993) Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 92:1436-1443
17. Druëke TB (1995) The pathogenesis of parathyroid gland hyperplasia in chronic renal failure. Kidney Int 48:259-272
18. Arnold A, Brown M, Ureña P, Gaz RD, Sarfati E, Druëke TB (1995) Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 95:2047-2053
19. Tominaga Y, Namii Y, Haba T, Uchida K, Numano M, Tanaka Y, Takagi H (1995) Monoclonal proliferation of nodules in parathyroid hyperplasia due to chronic renal failure (abstract). J Am Soc Nephrol 6:972
20. Messa P, Sindici C, Cannella G, Miotti V, Risaliti A, Gropuzzo M, Di Loreto PL, Bresadola F, Mioni G (1998) Persistent secondary hyperparathyroidism after renal transplantation. Kidney Int 54:1704-1713
21. Jehle PM, Jehle DR, Mohan S, Keller F (1998) Renal osteodystrophy: new insights in pathophysiology and treatment modalities with special emphasis on the insulin-like growth factor system. Nephron 79:249-264
22. Hruska KA, Teitelbaum SL (1995) Renal osteodystrophy. N Engl J Med 333:166-174
23. Koch Nogueira PC, Rey N, Saïd MH, Cochat P (1997) Evolution of hyperparathyroidism in children - effect of pre-emptive transplantation and duration of dialysis. Nephrol Dial Transplant 12:984-987
24. Parfitt AM (1997) The hyperparathyroidism of chronic renal failure: a disorder of growth. Kidney Int 52:3-9
25. Nieto J, Ruiz-Cuervas P, Escuder A, Regas J, Callis L (1997) Tertiary hyperparathyroidism after renal transplantation. Pediatr Nephrol 11:65-68
26. Singer GG, Delmez JA (1998) Effects of renal transplantation on bone and mineral metabolism. In: Bushinsky DA (ed) Renal osteodystrophy. Lippincott-Raven, Philadelphia, pp 473-498
27. Graziani G, Aroldi A, Castelnovo C, Bondatti F, DeVecchi A, Ponticelli C (1991) Ciclosporin and calcium metabolism in renal transplanted patients. Nephron 57:480-497
28. Dumoulin G, Hory B, Nguyen NU, Henriet MT, Bresson C, Regnard J, Saint-Hillier Y (1995) Lack of evidence that cyclosporine treatment impairs calcium-phosphorus homeostasis and bone remodelling in normocalcemic long-term renal transplant recipients. Transplantation 12:1690-1694
29. Aroldi A, Tarantino A, Montagnino G, Cesana B, Cocucci C, Ponticelli C (1997) Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients. Transplantation 3:380-386
30. Sugimoto T, Brown A, Ritter C, Morrissey J, Slatopolsky E, Martin KJ (1989) Combined effects of dexamethasone and 1,25-dihydroxyvitamin D3 on parathyroid hormone secretion in cultured bovine parathyroid cells. Endocrinology 125:638-641
31. Peraldi MN, Rondeau E, Jousset V, M'Selmi A el, Lacave R, Delarue F, Garel JM, Sraer JD (1990) Dexamethasone increases preproparathyroid hormone messenger RNA in human hyperplastic parathyroid cells in vitro. Eur J Clin Invest 20: 392-397
32. Traindl O, Längle F, Reading S, Franz M, Watschinger B, Klauser R, Woloszczuk W, Kovarik J (1993) Secondary hyperparathyroidism and acute tubular necrosis following renal transplantation. Nephrol Dial Transplant 8:173-176